Seibel, Nita L <br/><br/>
Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma: children's Cancer Group (CCG) 7943.  [electronic resource] 

 -  Cancer  Apr 2007 
 - 1646-53 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/cncr.22553  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bone Neoplasms--drug therapy<br/>Child<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Maximum Tolerated Dose<br/>Osteosarcoma--drug therapy<br/>Prognosis<br/>Survival Analysis<br/>Survival Rate<br/>Topotecan--administration & dosage